137 related articles for article (PubMed ID: 7620090)
1. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine.
Waite NM; Thomson LG; Goldstein MB
J Am Soc Nephrol; 1995 May; 5(11):1930-4. PubMed ID: 7620090
[TBL] [Abstract][Full Text] [Related]
2. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
[TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
Charest AF; McDougall J; Goldstein MB
Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.
Leonardi S; Praticò AD; Lionetti E; Spina M; Vitaliti G; La Rosa M
World J Gastroenterol; 2012 Oct; 18(40):5729-33. PubMed ID: 23155313
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
[TBL] [Abstract][Full Text] [Related]
6. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine.
Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O
Infection; 1995; 23(1):42-5. PubMed ID: 7744490
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
[TBL] [Abstract][Full Text] [Related]
8. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.
Goldwater PN
Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204
[TBL] [Abstract][Full Text] [Related]
9. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and side effects of intradermal hepatitis B vaccination in CAPD patients: a comparison with the intramuscular vaccination.
Chau KF; Cheng YL; Tsang DN; Choi KS; Wong KM; Chak WL; Chan YH; Li CS
Am J Kidney Dis; 2004 May; 43(5):910-7. PubMed ID: 15112182
[TBL] [Abstract][Full Text] [Related]
11. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination.
Propst T; Propst A; Lhotta K; Vogel W; König P
Am J Kidney Dis; 1998 Dec; 32(6):1041-5. PubMed ID: 9856522
[TBL] [Abstract][Full Text] [Related]
12. Intradermal vaccination of adults with three low doses (2 micrograms) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory.
Elisbão Mdo C; Baldy JL; Bonametti AM; Reiche EM; Morimoto HK; Pontello R; Matsuo T; Ferelle A; Neves J
Mem Inst Oswaldo Cruz; 2003 Dec; 98(8):1109-13. PubMed ID: 15049099
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly.
King JW; Taylor EM; Crow SD; White MC; Todd JR; Poe MB; Conrad SA; Gelder FB
Rev Infect Dis; 1990; 12(6):1035-43. PubMed ID: 2148433
[TBL] [Abstract][Full Text] [Related]
14. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
Sorkhi H; Dooki MR; Ebrahimnejad MS
J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
[TBL] [Abstract][Full Text] [Related]
15. [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach].
Poux JM; Ranger-Rogez S; Lagarde C; Benevent D; Denis F; Leroux-Robert C
Presse Med; 1995 May 6-13; 24(17):803-6. PubMed ID: 7630869
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
[TBL] [Abstract][Full Text] [Related]
17. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).
Ghebrehewet S; Baxter D; Falconer M; Paver K
Hum Vaccin; 2008; 4(4):280-5. PubMed ID: 18398298
[TBL] [Abstract][Full Text] [Related]
18. Immune response to intramuscular revaccination after primary intradermal vaccination against hepatitis B.
Pegues DA; Woodruff BA; Lambert SB; Tant MK; Woernle CH
Clin Infect Dis; 1995 Feb; 20(2):335-41. PubMed ID: 7742439
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion after additional vaccine doses to non-responders to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine.
Struve J; Aronsson B; Frenning B; Forsgren M; Weiland O
Scand J Infect Dis; 1994; 26(4):468-70. PubMed ID: 7984980
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal response following intradermal hepatitis B vaccine in infants.
Coberly JS; Townsend T; Repke J; Fields H; Margolis H; Halsey NA
Vaccine; 1994 Aug; 12(11):984-7. PubMed ID: 7975851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
